{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-002269","form_type":"8-K","ticker":"ATXI","cik":"0001644963","company_name":"AVENUE THERAPEUTICS, INC.","filed_at":"2022-01-07T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.544998+00:00","generated_at":"2026-06-27T19:53:34.457675+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Avenue Therapeutics CFO Joseph Vazzano resigns; CEO Lucy Lu appointed interim CFO","bullets":["Joseph Vazzano resigns as CFO effective Jan 14, 2022, to pursue other opportunities; no disagreement with company.","Vazzano will transition to a consulting role under a consulting agreement dated Jan 7, 2022.","Board appoints Dr. Lucy Lu, current President and CEO, as interim CFO and Principal Financial Officer."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-002269","json":"https://secwatch.observer/filing/0001104659-22-002269.json","markdown":"https://secwatch.observer/filing/0001104659-22-002269.md","text":"https://secwatch.observer/filing/0001104659-22-002269.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1644963/000110465922002269/0001104659-22-002269-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1644963/000110465922002269/tm221800d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T19:53:34.457675+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"56ee19615a","claim":"Joseph Vazzano departed as Chief Financial Officer at AVENUE THERAPEUTICS, INC..","evidence_excerpt":"Mr. Joseph Vazzano notified Avenue Therapeutics, Inc. (the “Company”) that he was resigning from his role as the Company’s Chief Financial Officer, effective January 14, 2022, to pursue other opportunities.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1644963/000110465922002269/0001104659-22-002269-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigning"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}